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Abstract 
Skin pigmentation, vitamin D inactivation and genetic variation of vitamin D binding 
protein (DBP) are all essential mechanisms for adaptive vitamin D metabolism in African 
children living near the equator. The widely used measurement of total serum 25-
hydroxyvitamin D (25OHD) test ignores their inherent differences and maladaptive 
vitamin D metabolism, and potentially misclassifies their vitamin D status in northern 
parts of the United States. The goal of this multi-center international cross-sectional 
observational study was to better define vitamin D status in Somali immigrants living in 
the northern US. Well children aged 6 months to 7 years from Minnesota (US-born of 
Somali descent, n=55) and in Uganda (n=95) were enrolled. 25OHD and other vitamin D 
metabolites (24,25(OH)2D) were measured by immune-affinity extraction and liquid 
chromatography-tandem mass spectrometry. Parathyroid hormone (PTH) and 
hypocalcemia status were used as indicators of insufficiency. DBP haplotypes were 
determined. Ninety-one percent of the Minnesota Somali participants had 25OHD levels 
<30 ng/mL (vs 48% in Ugandans). Compared to the Ugandan group, and despite better 
nutritional status (milk intake), MN Somali children had lower 25OHD (23.7 ng/mL vs 
30.1; p<0.0001) and calcium levels (9.1 mg/dL vs 9.5; p<0.0001), and higher PTH levels 
(47 pg/mL vs 36; p<0.0001). Somalis had a significantly higher frequency (57% vs 14% 
in Ugandans; p<0.001) of calcium in the lower level of normal even at 25OHD levels > 
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20 (American Academy of Pediatrics (AAP) cutoff for sufficiency). This was not 
significantly different from the Somali group with 25OHD < 20 (p<0.3). The high 
affinity allele Gc1f was the predominant DBP variant in both Somalis and Ugandans, yet 
MN Somalis had a higher percentage of low serum calcium status. The Somali group had 
significantly higher levels of vitamin D inactivation (higher 24,25(OH)2D) despite 
having lower 25OHD levels, raising a concern of maladaptive vitamin D metabolism and 
inherent susceptibility to vitamin D deficiency independent of limited cutaneous vitamin 
D synthesis as a result of darker skin tone. These results suggest that 25OHD levels 20-30 
ng/mL (above the AAP cutoff for sufficiency (>20 ng/mL)) are common in children of 
Somali descent in northern US, and are clinically significant. Also, while African 
children living near the equator possess adaptive mechanisms for acquisition and 
utilization of vitamin D, those same mechanisms could render them susceptible to 
insufficiency when migrating to high latitude regions such as the northern US. 
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Introduction 
Vitamin D, a prohormone, houses a group of fat soluble seco-sterols [1]. This 
essential vitamin is gained from exposure to sunlight, vitamin D rich diet as well as 
dietary supplements. The two main forms of vitamin D, vitamin D2 (synthesized by 
plants) and vitamin D3 (synthesized by animals), are found in either supplements or 
animal-based products, respectively [1]. Aside from the differences in chemical side-
chains, previous studies have found vitamin D3 intake to be more efficient in raising 
serum vitamin D levels, and more effective in the human body, as opposed to D2 [2]. 
Nonetheless, they both still are considered to be prohormones and precursors for the 
biologically active vitamin D, 1,25 dihydroxyvitamin D (1,25(OH)2D). In humans, 
vitamin D3 can be obtained from sunlight-mediated cutaneous synthesis (figure 1).   
 
 Sun exposure 
Dietary vitamin D     Serum 25OHD 
    Serum 1,25 (OH)2D 
Intestinal calcium absorption 
Cutaneous 7-hydrocholersterol 
+
CYP27B1 
1-α-hydroxylase
Hepatic hydroxylase 
Figure 1. Vitamin D sources and metabolism 
Abbreviations: 25OHD =25-hydroxyvitamin D; 1,25(OH)2D =1,25 
dihydroxyvitamin D; CYP27B1 =renal 1-α hydroxylase enzyme  
utaneous 7-dehydrocholesterol 
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Exposure to sunlight is the main source of vitamin D through the synthesis in the 
skin [3]. After the exposure of ultraviolet B radiation (wavelength 290 to 315 nm), the 
pre-vitamin compound is converted to vitamin D3 by the aide of 7-dehydrocholestrol 
enzyme in the skin [4]. Vitamin D undergoes hepatic hydroxylation via mitochondrial 
cytochrome P4502R1 (25-hydroxylase) enzyme, through a mostly unregulated catalytic 
step [5]. Therefore, the amount of vitamin D3 correlates with the availability of 7-
dehydrocholesterol, degree of ultraviolet B radiation and duration of exposure. Other 
factors that can influence the body acquisition of vitamin D via the cutaneous route 
include: the season, the latitude, and degree of skin pigmentation [6]. Serum 25-
hydroxyvitamin D levels tend to decrease during fall and winter seasons in areas with 
latitudes higher than 30 degrees N or S [6], especially in individuals with darker skin 
pigmentation or excessive use of covering and sunscreen.  
Apart from endogenously synthesized vitamin D, another source of vitamin D 
acquisition, to lesser degree, is the diet.  The main dietary sources of vitamin D are found 
in vitamin D rich foods and nutritional supplements. The total dietary intake of vitamin D 
includes dietary intake from both supplements and food, such as fatty fish, foods fortified 
with vitamin D, and beef, fish, and liver. In recent years, vitamin D supplements have 
become more commonly used. These supplements contain either D2 or D3. The current 
AAP (American Academy of Pediatrics) vitamin D supplementation recommendation for 
infants is 400 IU daily. Based on this guideline, pediatricians typically recommend 
supplementation for infants who are either breastfed or receiving less than 1 liter (33.8 
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ounces) of infant formula a day [7]. In the US, it is recommended that liquid milk be 
fortified with 400 IU of vitamin D per quart but this fortification is not mandated by 
governmental regulations. Studies have shown that liquid milk in the US actually 
contains varying percentages (62% to 120%) of the recommended amount for 
fortification [1]. Vitamin D fortified milk and foods are important sources of vitamin D in 
areas at higher latitudes with diminished hours of effective sunlight.    
Vitamin D, synthesized in the skin or absorbed from the diet, is transported to the 
liver where it is converted to 25-OHD by the CYP2R1 enzyme [1]. The newly 
synthesized 25-OHD binds to a vitamin D binding protein (DBP). The bound 25-OHD is 
hydrolyzed in the kidneys to its active form, also known as calcitriol or 1,25(OH)2D, by 
the CYP27B1 enzyme or alpha 1 hydroxylase. The process of vitamin D activation, 25-
hydroxyvitamin D to its active form calcitriol, takes place at the renal tubular cells. 
Megalin receptors at the luminal sides of the cells bind the 25-hydroxyvitamin D-DBP 
complex to induce an endocytosis process. Intracellularly, 25-hydroxyvitamin D-DBP 
complex is degraded in the lysosomes before being transported by intracellular binding 
protein to the mitochondria where alpha 1 hydroxylase enzyme carry out the 
activation/conversion process (25-hydroxyvitamin D or “calcidiol” to 1,25-
dihydroxyvitamin D or “calcitriol”). The intracellular processes depend on the successful 
megalin receptor mediated internalization of 25-hydroxyvitamin D-DBP complex (figure 
2). Therefore, DBP and megalin receptors both are essential for the process. DBP 
transports 25-hydroxyvitamin D and in turn prevents its loss in urine, and also plays a 
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role in Vitamin D delivery to tubular cells’ mitochondria. Megalin seems to primarily 
bind DBP bound 25-hydroxyvitamin D [5].  
Animal studies have shown that knock-out mutations of megalin render mice susceptible 
to rickets when placed on a vitamin D deficient diet. Interestingly, DBP knock-out 
mutation mice are not typically rachitic, suggesting an alternative route of activation, but 
they are found to be resistant to vitamin D intoxication, emphasizing the importance of 
DBP role in the conversion of the precursor vitamin D form 25-hydroxyvitamin D into its 
active form, dihydroxyvitamin D (1,25(OH)2D) or calcitriol [5]. Parathyroid hormone 
Figure 2. Renal tubular uptake of 25OHD-DBP complex and its activation 
Abbreviations: 25OHD =25-hydroxyvitamin D; 1,25(OH)2D =1,25 
dihydroxyvitamin D; RAP =receptor associated protein. 
Adapted from Dusso, et al., American Journal of Physiology 2005  
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(PTH) and phosphorus and fibroblast growth factor 23 (FGF23) levels all play an 
important role in regulating alpha 1 hydroxylase enzyme, and thus directly influence the 
availability of the active form of vitamin D. When there are low levels of calcium and 
parathyroid hormone, the CYP27B1 enzyme is stimulated to bind and convert inactive 
25-OHD to hydrolyze in the kidney (figure 1). Low serum phosphorus levels have direct 
and similar effects, whereas, FGF23 inhibits calcitriol production. Scientific evidence has 
long supported the importance of vitamin D action in skeletal bone turnover and calcium 
absorption.  
 
Actions of vitamin D as a hormone  
At the molecular level, in humans, vitamin D exerts its action via its biologically 
active form 1,25(OH)2D. Vitamin D receptor (VDR) transforms into heterodimer by 
interacting with retinoid X receptor after binding 1,25(OH)2D. Subsequently, a response 
element at the nuclear level influences activation or suppression of the tissue 
corresponding genes to bring about induction of protein transcriptions specific for 
vitamin D function. If it is the intestine, 1,25(OH)2D would promote claudin 2, CaBP 
(calcium transporter), and TRPV6 (calcium channel), to increase calcium absorption. In 
case of skeletal bones, vitamin D affects both osteoblast and osteoclast via RANKL, 
SPP1 (osteopontin) and osteocalcin, respectively [8]. VDR are found in various tissues 
and organs including bone, intestine, kidneys, immunocytes (T cells), as well as gonads, 
brain, colon and pancreas. VDRs are also found in parathyroid glands, playing a role in 
decreasing PTH synthesis and secretion in state of vitamin D sufficiency [9].   
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Vitamin D deficiency in African children  
Across the African continent there are climate, latitude, and nutritional, 
subpopulation (within the continent) variations that influence the prevalence of vitamin D 
deficiency [6]. In African children, biochemical vitamin D deficiency leads to clinical 
rickets alone or in conjunction with dietary calcium deficiency [10]. Another major factor 
leading to vitamin D deficiency in Africa is the burden of infectious disease [6]. 
Prevalence of infectious and chronic disease can be both the cause and effect of vitamin 
D deficiency. The latter is proven to be related to an increased susceptibility to infections 
due to the known immunomodulatory role of vitamin D [11]. On the other hand, relative 
insufficiency of vitamin D in the context of endemic infectious disease is believed to be 
associated increased vitamin D consumption or over utilization (figure 3) [6].  
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Figure 3. Factors affecting the availability and utilization of vitamin D 
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A recent study in Olmsted County, Minnesota has shed light on the increased 
incidence of nutritional rickets in children of African descent (220 cases per 100,000). 
Vitamin D deficiency and nutritional rickets incidence increased in Minnesota after 
Somali refugees’ arrival in and after 1994 (figure 4). In this study, in which 17 children 
had either nutritional rickets or rachitic radiological findings, the diagnosis was 
associated with black race (59% of all study participants with rickets out of whom 
majority were of Somali descent). The authors raised the possibility of dietary calcium 
deficiency as an explanation similar to a previous report of African children living in 
Africa [12].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Somali refugees 
arrival to 
Minnesota 
 
Figure 4. Increased incidence of nutritional rickets in Minnesota 
Adapted from Thacher et. al, Mayo Clin Proc. 2013 
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Definition of vitamin D status in African ethnicity and DBP polymorphism   
Vitamin D deficiency is a worldwide problem associated with rickets, fractures, 
weak immunity with increased susceptibility to infection, and malignancy [4, 13]. 
Because of the pleiotropic effects on multiple systems, it is important to ensure optimal 
vitamin D levels not only to correct deficiency, but also to avoid toxicity, which can have 
adverse consequences as well (hypercalcemia, hypercalciuria leading to 
nephrocalcinosis) [1]. Typically, parameters for defining vitamin D deficiency and the 
need for treatment are based on total 25OHD levels [14]. 
 However, recent studies have suggested that in some populations low total 
25OHD alone does not reflect a true vitamin D deficiency status, because it does not take 
into account DBP affinity for vitamin D [15, 16]. It has been postulated that the portion 
of 25OHD which is not bound to DBP represents a “bioavailable” form of vitamin D 
[17]. Thus, relying on the total 25OHD alone may misclassify patients as requiring 
treatment if their bioavailable vitamin D levels are normal. Previous studies in African 
Americans have shown that blacks tend to have not only lower total vitamin D levels 
compared to Caucasians, but also lower DBP levels, resulting in similar concentrations of 
estimated bioavailable 25OHD [17]. Vitamin D circulates in the bloodstream mostly 
bound to DBP (85-90%). About 10-15% is bound to albumin, and only <1% is in the free 
form (figure 5) [15]. There are important racial differences in the genetic polymorphisms 
of the DBP (GC) gene that determine DBP level and affinity for vitamin D [2]. The two 
most common single-nucleotide polymorphisms (SNPs) in the coding region of the DBP 
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gene are restrictive site variants rs4588 and rs7041 [17]. Multiple studies show a 
significant correlation between these restriction site variants and DBP levels and affinity. 
85-90%
10% 1%
DBP
Albumin
Free
Figure 5. Vitamin D metabolites transport in the blood  
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When considering total 25OHD levels, the cutoff between normal and abnormal 
levels should reflect clinical significance. Currently used cutoffs (table 1) of 25OHD 
levels in determining vitamin D deficiency were based on studies that utilized indicators 
such as radiologic changes, bone mineral density, PTH, and alkaline phosphatase levels 
[4]. The most sensitive biochemical indicator of vitamin D deficiency appears to be PTH 
level. Low levels of 25OHD are associated with higher than normal levels of PTH [18]. 
Research is still ongoing to clearly define the relationship between vitamin D deficiency 
status and PTH levels and the use of PTH as a biomarker for vitamin D biologic effect. In 
severe vitamin D deficiency rickets, 25 OHD is low and serum calcium and phosphorus 
are usually low, whereas alkaline phosphatase and PTH levels are elevated [4]. Certainly, 
biochemical vitamin D deficiency precedes radiological evidence of rickets. Therefore, 
the point of treatment is to prevent the development of florid rickets by detecting 
 
Source: Lee et. al J Pediatric Pharmacological Therapy 2013 
Table 1. Different national guidelines for cutoffs of vitamin D status  
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biochemical vitamin D deficiency early. Some studies looked at free form of 25OHD as 
an indicator of vitamin D status  
In the study by Powe et al. [17] the fraction of vitamin D not bound to DBP 
showed a better correlation with the level of PTH than total 25OHD. However, the 
authors used an immunoassay which has several limitations and a number of concerns 
were raised in the literature about its sensitivity, accuracy, and reliability. Importantly, 
polymorphisms themselves can affect antibody binding, confounding the interpretation 
[19].  The study by Powe et al. and its subsequent commentaries also raised many 
questions related to the physiological role of the bound vitamin D level [20], suggesting 
that it is the complex of 25OHD and DBP that is taken up by renal proximal tubular 
epithelial cells through receptor-mediated endocytosis, and that 25OHD within this 
complex is the major precursor for circulating 1,25-dihydroxyvitamin D. The latter is the 
active form of vitamin D that is important in the regulation of PTH levels. Thus, both 
total and free 25OHD appear to play a role in regulating calcium homeostasis and PTH 
secretion. The research focus continues to elucidate on the role of DBP as a modifier of 
vitamin D status and as a potential contributor to physiologic mechanisms that help 
humans to adapt to their endogenous climates.    
 
Adaptive vitamin D metabolism    
 The widely used measurement of total serum 25-hydroxyvitamin D (25OHD) test 
ignores racial differences and adaptive traits, yet remains the universal screening tool of 
vitamin D status [13]. Studies have shown that serum 25-hydroxyvitamin D does not 
   12 
 
always reflect state of sufficiency especially in some ethnic populations [14].  
 Total serum 25-hydroxyvitamin D, which serves as a precursor [16] and substrate 
for the active vitamin D, 1,25(OH)2D3  and shares the same binding transport protein 
(DBP), variably translates into calcium absorption and skeleton accretion based on many 
factors that include vitamin D binding protein (DBP) phenotype and its affinity to both 
metabolites [13] [16]. It is certainly logical to look at general physiologic compensatory 
processes, which are already in place for vitamin D and calcium homeostasis, for clues to 
draw estimations and indicators for vitamin D status, namely serum calcium level, PTH, 
and alkaline phosphatase (ALP) levels.  While it is established that ethnic variation in 
skin tones influence cutaneous synthesis of vitamin D, we are still learning about vitamin 
D inactivation and DBP genetic polymorphism and its distinctive racial distribution as an 
adaptive modifier to vitamin D status [14, 15, 20]. 
 In central African countries like Uganda with equatorial latitudes and abundant 
UVB light and when nutrition is optimal, skin pigmentation, the bio-degradation of 
cutaneously synthesized vitamin D into lumesterol or tachysterols (which are biologically 
inactive), suppressed PTH and accelerated enzymatic inactivation of vitamin D are all 
adaptive mechanisms to counter excessive generation and utilization of vitamin D, 
respectively [13, 21, 22] On the other hand, it is expected to find adaptive loss of skin 
pigmentation and efficient cutaneous generation of vitamin D with possible diminished 
inactivation in indigenous inhabitants of regions farther from equator, like in northern 
US, Canada, and Europe, to optimize vitamin D presence and action [13, 21, 22]  (figure 
6 and figure 7). Other inherent adaptive mechanisms to local populations where there is 
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either abundance or scarcity of UVB light include, first, the inactivation pathways for 
vitamin D metabolite that involve CYP24 enzyme, and second, DBP polymorphism. 
Firstly, the significance of CYP241A enzyme in vitamin D metabolism can be 
appreciated in the congenital infantile hypercalcemia where the deficient enzyme is 
associated with unregulated production of 1,25 OH2D3 [23]. It is well established that 
24,25(OH)2D can correlate well with and reflect 25OHD levels because CYP241A 
enzyme activity is directly influenced by  vitamin D receptor activity and the level of 
conversion product of 25OHD, 1,25 (OH)D. The relationship of the intermediate 
metabolite of inactivation pathway, 24,25 OH2D3, and serum calcium is as not simple as 
one would expect [14]. It is expected to see in vitamin D sufficiency state 24,25 OH2D3 
increases and vice versa (figure 7) .  
Figure 6. Vitamin D synthesis: cutaneous adaptation to various intensities of sun 
  
Abbreviations: UV-B =ultraviolet-B 
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 Secondly, there are several studies that focused on exploring the role of the 
genetically determined and racially distributed DBP and whether it can significantly 
modify vitamin D status among different ethnic populations. Although current evidence 
contradicts the previous notion of ethnic difference in DBP levels in African American 
when compared to Caucasians in the US, the question about DBP affinity in relation to its 
bound and unbound vitamin D metabolite still remained unanswered. Furthermore, free 
1,25(OH)2D levels appear to be well maintained even in the context of  liver disease and 
reduced DBP levels [24]. This fact should raise speculation of the role of genetically 
determined DBP affinity in gauging the bioavailability of free vitamin D metabolites, 
25OHD - for which there is no known receptor yet - and 1,25(OH)2D which exerts the 
 
Figure 7. Post cutaneous adaptive vitamin D metabolism:  increased sun exposure 
favors inactivation of vitamin D 
Abbreviations: 25OHD =25-hydroxyvitamin D; 1,25(OH)2D =1,25-
dihydroxyvitamin D; 24,25(OH)2D =24,25-dihydroxyvitamin D; CYP27B1 =1-α 
hydrolase enzyme; CYP24A1 =24,25 hydroxylase enzyme  
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biological action of vitamin D including maintaining serum calcium.  
 It is established that a decline in extracellular ionized calcium is what triggers PTH 
elevation. Kruse’s study described hypocalcemia (serum calcium <8.4 mg/dl) in stage 1 
of deficiency in children age 2-3 months [18]. The first mechanism of maintaining serum 
calcium is PTH independent and relies on 1,25(OH)2D action in the intestine 
(particularly in duodenum and jejunum) enhancing calcium absorption [1]. Seasonal 
fluctuation of serum calcium between winter and summer, with the nadir observed in 
winters (diminished sun exposure), has been described in the literature [25]. In the 
absence of dietary calcium deficiency, mild subclinical hypocalcemia could be an 
indicator of vitamin D deficiency particularly in immigrant populations in regions farther 
from the equator. 
 In indigenous populations living in their local climates and latitudes, skin 
pigmentation, vitamin D inactivation and genetic DBP polymorphism seem to be 
essential for adaptive vitamin D metabolism.  In the wake of a recent history of increased 
human immigration and displacement to regionswith latitudes for which they have no 
adaption, in addition to nutritional influences, these adaptive mechanisms may pose 
differential susceptibility for vitamin D insufficiency.  Thus, it is conceivable that we 
may find in these immigrant populations vitamin D acquisition, metabolism, and 
physiologic compensation that may pose differential susceptibilities for insufficiency 
status manifested as lower 25OHD levels, mild subclinical hypocalcemia, and PTH 
elevation. Due to the known inter-generational genetic mix between African Americans 
and Caucasians and generational adaptation, we wanted to examine these research 
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questions and compare US children of first generation African decent to African children 
living in Africa. We hypothesize that:    
 
1. Vitamin D levels 20-30 ng/ml (considered sufficient under current AAP 
guidelines) will be common in Somali immigrant children living in Minnesota 
and will be clinically significant as evidenced by calcium levels that are lower and 
PTH levels that are higher than established age-adjusted normal values.  
2. DBP haplotypes in Somali immigrant children will be predominantly high- and 
intermediate-affinity  
3. Ugandan children living in Uganda will have higher vitamin D levels, less 
hypocalcemia and lower PTH levels than the Minnesota Somali children despite a 
similarly low prevalence of low-affinity DBP haplotypes 
 
In our study, where we recruited well African children in a high latitude location (MN) 
mostly during winter as well as African children in equatorial latitude (Uganda), our aim 
was to determine if the AAP defining the cutoff level for vitamin D insufficiency (<20 
ng/ml) is appropriate for the children of Somali immigrants living in northern US. 
 
Methods  
 
Study population and design 
 
 This is a multi-center international cross sectional observational study. The study 
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population consisted of 150 participants. There were two recruitment centers, one in the 
United States and the other in Uganda. Recruitment in the city of Minneapolis enrolled 
61 well US-born children of Somali descent. Additionally, a total of 99 well Ugandan 
children were enrolled from the city of Kampala. Local and international Institutional 
review board approvals were obtained and all participants’ parents/caregivers provided 
informed consent. In Minneapolis, MN, latitude N 45, recruitment primarily took place at 
the community level. The majority of enrollees (n=49) had their blood drawn in the 
winter months of 2016, with a few participants joining the study in the spring (n=6 
Somalis). In equatorial Kampala-Uganda, where children are seen for well child checks 
and immunizations at Mulago hospital, parents and caregivers were approached and 
invited for participation. Likewise, children who attended surgical clinic for otherwise 
minor surgical problems (e.g. hernia, hydrocele, and benign skin lesions) were also 
screened for enrollment. For all study groups, there were a total of 10 exclusions: 6 
Somali children had inadequate blood samples and 4 Ugandan children had (after 
enrollment) questionable calcium intake (n=2), malaria (n=1), or malnutrition (n=1), 
making a total of 150 study participants: 55 Somali and 95 Ugandan.   Those who gave  
consent and were deemed eligible participants were sent for blood draw. US and Africa 
samples were batched and measured in the same US laboratory for testing.  
Measurements of Vitamin D and its metabolites 
The University of Washington, Department of Laboratory Medicine performed 
vitamin D metabolite measurements. Quantification of 1,25-dihydroxy vitamin D2 
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[1,25(OH)2D2] 1,25-hydroxy vitamin D3 [1,25(OH)2D3], 24,25-dihydroxyvitamin D3 
[24,25(OH)2D3], 25-hydroxyvitamin D2 [25OHD2], and 25-hydroxyvitamin D3 
[25OHD3] in participants’ serum was carried out by using immunoaffinity extraction and 
liquid chromatography-tandem mass spectrometry (LC-MS/MS). Patient serum, 
calibrators, and controls (400 μL) were spiked with deuterated internal standards and 
immunoaffinity purified using anti-1α,25-dihydroxyvitamin D beads from ALPCO. After 
incubation, the beads were washed and bound analytes are eluted with organic solvent. 
The eluent was dried down and the residue reconstituted with the derivatizing agent 
PTAD in acetonitrile. After incubation at room temperature, the reaction was quenched 
with water. A portion of the mixture was analyzed on a Waters Xevo TQ tandem mass 
spectrometer equipped with an Acquity UPLC. Analytes included 25(OH)D2, 25(OH)D3, 
24,25(OH)2D3, 1,25(OH)2D2, and 1,25(OH)D3 with deuterated internal standards for 
each analyte included. Standards were prepared in stripped human serum. The ability to 
multiplex the analyses was facilitated by the non-specific binding of multiple vitamin D 
metabolites the ALPCO beads. Importantly, the beads did not bind C-3 epimers of 
vitamin D nor did they bind 4β,25-dihydroxyvitamin D.  
Vitamin D binding protein measurement and haplotype assignment 
The University of Washington, Department of Laboratory Medicine performed the 
quantification of vitamin D binding protein in participants’ serum. Patient serum, 
calibrators, and controls (10 µL) were denatured, reduced, and alkylated before being 
proteolytically digested with trypsin. Peptides that were liberated from vitamin D binding 
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globulin (in addition to spiked internal standard peptides) were specifically quantified 
using liquid chromatography-tandem mass spectrometry and compared with a calibration 
curve to determine that concentration of protein in the sample. Other peptides were 
monitored in order to assign the polymorphisms present in the sample, which correctly 
assigned the genotype 97% of the time [19]. 
 
Mineral metabolism markers  
 Samples were obtained, immediately processed by serum separation (centrifuge), 
transported in dry ice and stored at −80 °C before analysis.  Serum intact PTH 
concentration was measured using chemiluminescent immunoassay at Fairview 
laboratory service, West Bank Acute Care Laboratory. Serum albumin using polychromic 
end point methods, calcium, phosphorus, and magnesium using bichromatic endpoint, 
and alkaline phosphatase using bichromatic rate methods were also performed utilizing 
Siemen’s Vista platform at Fairview laboratory service. 
 
Data collection  
 After securing inform consents, participants’ parents/caregivers were briefly 
interviewed to fill and survey questions.   Subjects were screened for study eligibility.  
Subjects with calcium, vitamin D supplements intake, chronic liver or kidney disease, 
bone disease recent fracture, acute illness, on chronic medications for HIV, seizure, or 
glucocorticoids, history of prematurity, younger than 6 months or older than 7 years, self-
identified as not Ugandan, or Somali were excluded.   The subjects were surveyed for 
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vitamin or calcium supplementation, breastfeeding, nutritional restrictions, hours per day 
of sun exposure, and quantity of liquid milk intake (cups per day to generate average per 
week).  An estimate of daily calcium intake was based on average daily milk intake (8 oz 
cup of cow milk contains 270 mg of calcium).  Weight was measured using a well 
calibrated scale (local clinic scale in Uganda UNICEF SALTER ENGLAND Model 235 
6S); WHO chart was used for weight and height to determine eligibility (children with 
weights or weights for height less than 2 SD deviation participants were excluded). 
Height was measured by using tape, from the base of the floor to the marked 
measurement on the wall.  
 
Statistical analysis 
 T-test was used to compare baseline characteristics of age, BMI, PTH, ALP, 
vitamin D metabolites, minerals, milk, calcium intake, and hours of sun exposure. Fisher 
exact and Chi-square tests were used to compare proportions of gender, low calcium, and 
low 25OHD. Linear correlation and Pearson correlation coefficient values were generated 
for continuous variables. Statistical software used to carry out analysis were SAS® 9.3 
and Prism GraphPad® 7.3 
 
 
 
 
 
   21 
 
Results 
 The study population consisted of 150 participants. From the city of Minneapolis 
we enrolled 55 well US-born children of Somali descent (Somali group). The majority of 
enrollees (n=49) had their blood drawn in the winter months of 2016 (January-February-
March), with few participants joined the study in the spring (n=6). A total of 95 well 
Ugandan children were enrolled from equatorial Kampala-Uganda.  
 
 
 
 
 
 
 
 
 
 
 
Ugandan participants were younger in age (average 1.7 years) and the majority of them 
were breastfed. Compared to Ugandan children, the Somali group had better nutrition in 
terms of milk intake (vitamin D fortified), calcium intake, and a higher percentage use of 
multivitamins (table 2A). 
 
Table 2A. Participants’ characteristics 
Groups  
(n=150) 
Somalis 
(n=55) 
Ugandans 
(n=95) 
P-values 
 
Age (years), mean (SE) 4.7 (0.2) 1.7 (0.2) <0.0001 
Male, no. (%) 24 (43.6) 50 (50.5) 0.4 
Weight SDS, SE 1 (1.1) 0.2 (1) <0.0001 
Height SDS, SE 1.9 (1.3) -0.2 (1.4) <0.0001 
MTV intake, no. (%) 10 (18.2) 1 (1.1) <0.0001 
Milk intake* (cup/wk), mean (SE) 15.5 (1.1) 9.4 (0.8) <0.0001 
Daily calcium intake** (mg/day), mean >597 >361 <0.0001 
Hours sun, mean (SE) 2.8 (0.4) 4.7 (0.27) <0.0001 
Abbreviations: MTV =multivitamins; SE =standard error; SDS =standard 
deviation score;  *milk intake was underestimated in Ugandans due to 
breastfeeding; **calcium intake calculated based on estimated calcium content 
of 8 Oz (240 mL) cow milk (270 mg) 
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 More than 90% of Somali immigrant children living in Minnesota had 25OHD 
levels less than 30 ng/ml. This was associated with a high prevalence of calcium levels 
below the lower limit of normal for age, and lower minerals averages (phosphorus, and 
magnesium), compared to Ugandan children (table 2B). Vitamin D levels <30 ng/ml were 
much less common in children living in Uganda, but for those with 25OHD levels <30, 
the prevalence of calcium levels below the lower limit of normal and PTH levels were 
lower than in Minnesota Somali children. Ugandans, who live at the equator, had 
Table 2B. Participants’ laboratory characteristics 
Groups  
(n=150) 
Somalis 
 (n=55) 
Ugandans  
(n=95) 
P-values 
  
25OHD (ng/ml) mean (SE) 23.7 (1) 30.1 (0.8) <0.0001 
1,25 (OH)2D (pg/ml) mean (SE) 62.27 (1.5) 126 (3.5) <0.0001 
24,25(OH)2D (ng/ml) mean (SE) 1.5 (0.07) 1.15 (0.06) <0.001 
25OHD % <30 ng/ml 91 48 <0.0001 
25OHD % <20 ng/ml 24 11 0.0359 
Total calcium, mean (SE)* 9.1 (0.1) 9.5 (0.04) <0.0001 
Low serum calcium (%)** 51.9 13.7 <0.0001 
Phosphorus, mean (SE) 4.7 (0.1) 4.9 (0.06) <0.01 
Magnesium, mean (SE) 2.1 (0.02) 2.3 (0.02) <0.0001 
PTH (pg/ml), mean (SE) 47 (3) 35.8 (2) <0.01 
ALP, (U/L) mean (SE) 263 (14) 302.4 (11) 0.081 
High/medium affinity DBP  haplotype % 82 77 0.5 
Low Affinity DBP haplotype % 18 23 0.45 
ALP =alkaline phosphatase;  PTH =intact parathyroid hormone; 25OHD =total 
25-hydroxyvitamin D 2&3; 1,25(OH)2D =total 1,25-dihydroxyvitamin D 2&3; 
24,25(OH)2D =total 24,25-dihydroxyvitamin D 2&3 DBP =vitamin D binding 
protein; *total serum calcium and corrected for albumin; **low serum calcium 
(total, albumin corrected), low for age and laboratory reference (<8.5 mg/ml for 
age <1 year and <9.1 for age >1 year)   
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significantly higher hours of sun exposure (table 2A).  
 Using the cutoff of insufficiency defined as 25OHD level less 30 ng/ml (Endocrine 
society guideline), 49% of Ugandan children living in Africa at the equator had vitamin 
D insufficiency with only 13.7% (out of all Ugandan group) with low calcium levels. 
Whereas, percentage vitamin D insufficiency – based on the same cutoff – in Somali 
Minnesotans was 91% with 52% of them (out of all Somali group) having low calcium 
levels. In spite of adequate daily calcium intake (average 600 mg/day calcium from milk 
alone) and even at 25OHD levels above 20 (AAP cutoff for sufficiency), a significant 
percentage of participants had low calcium for age per laboratory reference values; 
Among Somalis with 25OHD levels less than 20 ng/ml (n=13), their hypocalcemia 
percentage was 38.5%, not significantly different from 56% for those (n=37) with 
25OHD level less than 30 but higher than 20 ng/ml (table 3).  
 
 
 
 
 
 
 
 
 
 
Table 3. Metabolic indicators for similarly low 25OHD levels in Somalis and 
Ugandans 
  
  
  
Somalis (n=55) Ugandans (n=95) 
25OHD cut-off levels 
(ng/ml) 
25OHD cut-off levels 
(ng/ml) 
(20-30)  <20 (20-30) <20 
N 37 13 36 10 
Average 25OHD (ng/ml) 24 17 25 16 
Average serum calcium, 
mg/dl 
9 9.1 9.5 9.5 
%Ca<LLN 57 39 17 10 
Average PTH (pg/ml),  48 47 37 48 
N = number; PTH =intact parathyroid hormone; 25OHD =25-hydroxyvitamin D, 
LLN =lower limit of normal =serum calcium (total, albumin corrected) low for 
age and laboratory reference 
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Both of the groups DBP haplotype consisted of Gc1f as the predominant allele. Both 
Somali and Ugandan children had DBP haplotypes which were predominantly high and 
intermediate affinity, with ≤25% low affinity DBP haplotypes (figure 8). The children of 
Somali descent group tended to have a higher percentage of low calcium for laboratory 
reference when they possessed the high affinity haplotype (Gc1f/Gc1f) as compared to 
those possessing the intermediate affinity haplotype (69.5 % vs 40.9%, p-value = 0.05) 
(table 4).  
H A I
A L A
0
2 0
4 0
6 0
8 0
S o m a lis
U g a n d a n s
%
K e y : H A = G c 1 f/G c 1 f, IA = G c 1 f/G c 1 S , L A = o th e rs
Figure 8. DBP haplotypes distribution 
HA =affinity; IA =intermediate or medium affinity; LA =low affinity binding 
protein haplotypes. Gc1f and Gc1S are vitamin D binding protein (Gc) gene 
variants 
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After adjusting for milk intake and BMI, 25OHD and PTH levels comparison between 
the two groups by haplotypes, (high affinity Gc1f/Gc1f vs intermediate affinity 
Gc1f/Gc1s, only variants with enough sample size to compare), showed that, unlike 
intermediate affinity, higher affinity haplotype levels of 25OHD differed significantly 
between groups with Ugandans once again having higher levels of 25OHD and lower 
levels of PTH (table 5).     
 
 
 
 
 
 
 
 
Table 5. Vitamin D metabolism indicators compared by haplotypes 
High affinity haplotype (Gc1f/Gc1f) Intermediate Affinity haplotype 
(Gc1f/Gc1s) 
Ugandans (n=58) minus Somalis (n=23) Ugandans (n=13) minus Somalis (n=22) 
 Not 
adjusted 
Adjusted * Not adjusted Adjusted* 
25OHD, 
Estimate (SE) 
7.7 (1.8) 8.8 (2.1) 6.1 (2.6) 7.23 (2.8) 
P-value <0.0001 <0.0001 0.02 0.01 
PTH, Estimate 
(SE) 
-13.5 
(4.9) 
-11.2 (5.5) -8.8 (6.9) -8.0 (7.4) 
P-value 0.006 0.045 0.205 0.28 
*Adjusted for milk intake (US milk is vitamin D fortified); 25OHD =25-
hydroxyvitamin D;  PTH =parathyroid hormone   
 
Table 4. Within group comparison of vitamin D metabolism indicators by DBP 
haplotype:  high affinity ( Gc1f/Gc1f) vs intermediate affinity ( Gc1f/Gc1s)  
 Somalis   Ugandans  
DBP haplotype Gc1f/Gc1f 
(n=23) 
Gc1f/Gc1s 
(n=22) 
P-
value 
Gc1f/Gc1f 
(n=58) 
Gc1f/Gc1s 
(n=13) 
P-
value 
PTH, mean (SE) 47.1 (18.5) 47.2 (18.5) 0.1 33.6 (24) 38.4 (24) 0.4 
25OHD, mean 
(SE) 
23.4 (6.7) 24.8 (4.6) 0.4 31.1 (9.1) 30.85 (9) 0.9 
% 25OHD<30 87% 91% 0.6 40% 38% 0.9 
% low calcium* 70% 40%  0.05 16% 8% 0.5 
Gc1f and Gc1S are vitamin D binding protein (Gc) gene variants; PTH =intact 
parathyroid hormone; 25OHD =25-hydroxyvitamin D; * =serum calcium (total, 
albumin corrected) low for age and laboratory reference   
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Despite the observation that Ugandan children had much higher 25OHD, 1,25(OH)2D 
levels and low PTH, indicating less overall vitamin D insufficiency, they had on the other 
hand a much lower 24,25(OH)2D compared to Somali children (figure 9). We found a 
clear strong and positive correlation between 24,25(OH)2D and 25OHD in both groups 
but not with serum calcium; the Somali group had distinctively higher levels of vitamin D 
inactivation (24,25(OH)2D)  relative to 25OHD levels (figure 10). 
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Figure 9. Vitamin D inactivation relative to 25OHD level  
Abbreviations: 24,25(OH)2D =24,25-dihydroxyvitamin D; 
25OHD =25-hydroxyvitamin D; VDI = the ratio between 
participants’ 24,25(OH)2D relative to 25OHD level 
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Figure 10. For a given 25OHD level, Minnesota Somali children had dramatically 
less 1,25(OH)2D and more 24,25(OH)2D 
Abbreviations: 25OHD =25-hydroxyvitamin D; 1,25(OH)2D =1,25-
dihydroxyvitamin D; 24,25(OH)2D =24,25-dihydroxyvitamin D 
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Discussion 
25OHD level as an indicator of vitamin D status  
Measurement of serum total 25OHD level remains a widely used screening tool for 
vitamin D status. In our study, we demonstrated that despite relatively better nutrition 
(intake of fortified milk, calcium and vitamin D supplementation) in the Somali group, 
we observed lower vitamin D and minerals levels (calcium, phosphorus and magnesium) 
and higher PTH levels compared to the Ugandan group, where higher 25OHD and 
minerals levels and lower PTH levels were observed. It is clear that UV-B exposure 
qualitatively (equatorial latitude) and quantitatively (number of hours of sun exposure) 
outweighs nutrition as a determinant of 25OHD level. With the marked availability of 
vitamin D supplementation and the emergence of evidence establishing associations 
between vitamin D deficiency and other non-skeletal health outcomes, it has become 
increasingly crucial to accurately define deficiency to allow prompt and appropriate 
treatment and avoid over-diagnosis and potential over treatment complications like 
vitamin D toxicity and nephrocalcitonosis. Despite the reported impaired calcium 
absorption and negatively affected bone mineral density that prompted changing the 
lower limit of insufficiency cutoff in adult to 30 ng/ml (ENDO guidelines), current 
guidelines for defining insufficiency in children remain at <20 ng/ml awaiting new 
research in infant and children [4]. In our study, if current AAP vitamin D insufficiency 
guidelines (<20 ng/ml) were to be applied to US children of Somali decent, with the 
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incidence of hypocalcemia and elevated PTH as a true outcome of insufficiency, a 
significant portion of them would be misclassified as having adequate levels of vitamin 
D. While this cutoff may be appropriate for Caucasian children or African Americans
who underwent generational genetic mix and perhaps adaptation, it seems inappropriate 
in diagnosing insufficiency in children of early generation African immigrants.  
Mild hypocalcemia as an outcome of vitamin D deficiency 
Having statistically significant different average PTH levels between the high 
vitamin D  high calcium group (Ugandans) and the mostly low vitamin D low calcium 
group (Somalis) indicates the physiologic significance of such a difference in serum total 
calcium (mean difference of 0.4 mg/dl). Although the relatively small percentage of 
hypocalcemia in the Ugandan group can be attributed to deficient calcium intake and not 
merely vitamin D deficiency or a combination of both, hypocalcemia in the Somali group 
must have been in association of vitamin D deficiency as their reported calcium intake   
was adequate based on current guidelines for dietary calcium [1]. One of the limitations 
to this assessment, however, includes the lack of knowledge about participants’ ionized 
calcium status. We also do not have an estimate of hypocalcemia effect on bone mineral 
density in study participants.  
Vitamin D binding protein genetic polymorphism and vitamin D inactivation 
This study illustrated the distribution of different variants of DBP with an attempt 
to understand its impact in modifying vitamin D status. Both the Somalis and the 
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Ugandan group had Gc1f as the predominant allele. The Ugandan group had  slightly 
higher percentage of homozygous high affinity Gc1f allele, but they both consistently 
exhibited low percentages of low-affinity alleles. This observation may be consistent with 
the difference in ancestral origins of both groups. Although we did not observe a direct 
modifying effect in 25OHD-PTH relation, there were some interesting findings. As a 
group, Ugandans had higher vitamin D levels and lower PTH when compared to the 
Somalis. At the level of haplotype affinities, the difference in average PTH and 25OHD 
levels between Somalis minus Ugandans is maintained for high affinity participants 
(Gc1f/Gc1f) but gets attenuated for the lower affinity (Gc1f/Gc1s). It seems that high 
affinity participants have tendency to be susceptible to vitamin D insufficiency. It is 
possible that this high affinity DBP allele is part of the equatorial adaptive vitamin D 
metabolism to the abundance and excessive synthesized 25OHD from sun light where 
vitamin D action is somewhat curbed by a tighter affinity thus diminishing bioavailable 
active vitamin D from exerting excessive calcium absorption. It is possible that for 
25OHD, high affinity DBP prevents urinary loss and drives tubular endocytosis of DBP-
25OHD complex for activation leading to high intracellular total 1,25OH2D that 
similarly unable to escape the tighter affinity after joining the DBP in the blood stream. 
We wonder if higher intra-tubular cells 1,25(OH)D in this haplotype could trigger 
relatively more mitochondrial enzyme CYP241, an activity attributing to the observed 
efficient inactivation pathways for both metabolites (25OHD and 1,25(OH)D). 
 
 It is unclear of how DBP variants with different affinities affect the catalytic 
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capacity of inactivation enzyme CYP241A. It was clearly observed in the Somali group - 
who had an overall similar DBP variants to the Ugandans – that they possessed high 
inactivation metabolite 24,25(OH)2D levels, indicating another unknown genetic 
difference between the two populations. Somali ancestrally come from Nile-Saharan or 
African-Asian who are typically exposed directly to excessive intense sun light, whereas 
Ugandans descend from Africa Southeastern Bantu ethnicity that inhabited the shaded 
jungles of equatorial Africa. Do Somali children living in Somali have similar vitamin D 
metabolism to Minnesota children of Somali immigrants?  And could immigrant 
Ugandans living in northern or southern latitudes have similar increased inactivation 
phenomena, suggesting unknown environmental influence? Further research is needed to 
further elucidate these interesting scientific questions  
Conclusions 
While well-nourished African children at the equator possess adaptive mechanisms 
for acquisition and utilization of vitamin D such as darkly pigmented skin and genotypes 
that favor high affinity vitamin D binding (reducing availability of active free vitamin D), 
those same mechanisms can render them susceptible to insufficiency when migrating to 
high latitude regions like in northern US.  
The current American Academy of Pediatrics cutoff level of insufficiency of serum 
25OHD at < 20 ng/ml, may not be appropriate to apply to this population. Because of 
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lower calcium and higher PTH levels in Minnesota Somali children with vitamin D levels 
<30 ng/ml, supplementation should be offered to these children. Ugandan children use 
vitamin D more efficiently, with greater conversion of 25OHD to 1,25(OH)2D and less 
inactivation via 24, 25(OH)2D than Somali children.  This is likely due to the genetic 
differences between the populations which make Somalis even more susceptible to 
vitamin D deficiency when they move away from the equator. Further research is needed 
to explore the observed unusually high degree of vitamin D inactivation in Somali 
children  
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